Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Feb 17, 2015 03:35PM Form SC 13G/A EXACT SCIENCES CORP Filed by: ORBIMED ADVISORS LLC
Feb 17, 2015 03:34PM Form SC 13G IRONWOOD PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 17, 2015 03:32PM Form SC 13G CERUS CORP Filed by: ORBIMED ADVISORS LLC
Feb 17, 2015 03:29PM Form SC 13G/A Bacterin International Filed by: ORBIMED ADVISORS LLC
Feb 17, 2015 03:29PM Form SC 13G ARRAY BIOPHARMA INC Filed by: ORBIMED ADVISORS LLC
Feb 17, 2015 03:27PM Form SC 13G/A Biodel Inc Filed by: ORBIMED ADVISORS LLC
Feb 17, 2015 03:25PM Form SC 13G/A ARROWHEAD RESEARCH CORP Filed by: ORBIMED ADVISORS LLC
Feb 17, 2015 03:22PM Form SC 13G/A AFFYMETRIX INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2015 04:14PM Form 13F-HR ORBIMED ADVISORS LLC For: Dec 31
Feb 12, 2015 04:14PM Form SC 13D Ascendis Pharma A/S Filed by: ORBIMED ADVISORS LLC
Jan 30, 2015 04:18PM Form SC 13D/A Otonomy, Inc. Filed by: ORBIMED ADVISORS LLC
Jan 23, 2015 04:21PM Form SC 13D/A RESPONSE BIOMEDICAL CORP Filed by: ORBIMED ADVISORS LLC
Nov 14, 2014 04:16PM Form 13F-HR ORBIMED ADVISORS LLC For: Sep 30
Sep 19, 2014 05:27PM Form SC 13D Affimed N.V. Filed by: ORBIMED ADVISORS LLC
Aug 28, 2014 05:13PM OrbiMed Advisors Lowers Stake in Intercept Pharma (ICPT) to 7.00%
Aug 28, 2014 04:52PM Form SC 13D/A INTERCEPT PHARMACEUTICAL Filed by: ORBIMED ADVISORS LLC
Aug 22, 2014 04:03PM Form SC 13D Otonomy, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 19, 2014 05:13PM Form SC 13D/A Relypsa Inc Filed by: ORBIMED ADVISORS LLC
Aug 14, 2014 04:23PM Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
Aug 8, 2014 04:31PM Form SC 13D Loxo Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 1, 2014 03:21PM Form SC 13D/A Anthera Pharmaceuticals Filed by: ORBIMED ADVISORS LLC
Jul 25, 2014 04:46PM Form SC 13D Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 9, 2014 01:21PM PlacementTracker Publishes First Half 2014 PIPE Market League Tables
Jul 2, 2014 01:00AM Seragon Pharmaceuticals Announces Acquisition Agreement With Genentech
Apr 8, 2014 11:00AM PlacementTracker Publishes First Quarter 2014 PIPE Market League Tables
Sep 23, 2013 06:29AM SciClone Pharma (SCLN) Names Nancy Chang as Director
Feb 6, 2013 09:50AM BioLineRx (BLRX) Enters 2.7M ADS DIrect Placement
Oct 2, 2012 05:13PM OrbiMed Advisors Lowers Stake in Athersys, Inc. (ATHX) to 3.48%
Aug 23, 2011 09:40AM VIVUS (VVUS) Enters $45.8M Direct Offering
Jul 5, 2011 11:18AM OrbiMed Advisors Shows New 5.07% Stake in Exact Sciences Corp (EXAS)
Jul 5, 2011 11:16AM OrbiMed Advisors Shows New 5.36% Stake in Affymax, Inc. (AFFY)

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed